Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

YEAR 5 - CHEMPATH > ChemPath: Assessment of Renal Function 2 > Flashcards

ChemPath: Assessment of Renal Function 2 Flashcards

1
Q

Define AKI.

A

Rapid reduction in kidney function, leading to inability to maintain electrolyte, acid-base and fluid homeostasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three stages of AKI?

A

Stage 1: increase in serum creatinine by 1.5-1.9 times baseline

Stage 2: increase in serum creatinine by 2-2.9 times baseline

Stage 3: increase in serum creatinine by >3 times baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is pre-renal AKI?

A

AKI caused by reduced renal perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the normal response to reduced circulating volume.

A
  • Activation of central baroreceptors and renin-angiotensin system
  • Release of vasopressin
  • Activation of sympathetic system
  • Results in vasoconstriction, increased cardiac output and renal sodium retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name and describe the two mechanisms that maintain renal blood flow despite changes in systemic blood pressure.

A
  • Myogenic stretch - if the afferent arteriole gets stretched due to high pressure, it will constrict to reduce the transmission of that pressure to the glomerulus
  • Tubuloglomerular Feedback - high chloride concentration in the early distal tubule (suggestive of high GFR) stimulates constriction of the afferent arteriole which lowers GFR and, hence, chloride concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List some causes of pre-renal AKI.

A
  • True volume depletion
  • Hypotension
  • Oedematous state
  • Selective renal ischaemia (e.g. renal artery stenosis)
  • Drugs affecting renal blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List some drugs that affect renal blood flow.

A
  • ACE inhibitors - reduce efferent arteriolar constriction
  • NSAIDs - decreased afferent arteriolar constriction
  • Calcineurin inhibitors - decrease afferent arteriolar constriction
  • Diuretics - affect tubular funciton and decrease preload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a consequence of prolonged pre-renal insult?

A

Acute tubular necrosis (ATN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What might be seen on urine microscopy in a patient with ATN?

A

Epithelial cell casts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes post-renal AKI?

A

Physical obstruction of urine flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List some sites of urine obstruction.

A
  • Intra-renal
  • Ureteric
  • Prostatic/urethral
  • Blocked urinary catheter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline the pathophysiology of post-renal AKI.

A
  • GFR is dependent on a hydraulic pressure gradient
  • Obstruction results in increased tubular pressure
  • This results in an immediated decline in GFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some consequences of prolonged renal obstruction?

A
  • Glomerular ischaemia
  • Tubular damage
  • Long-term interstitial scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the possible sites of disease in intrinsic AKI.

A
  • Vascular (e.g. vasculitis)
  • Glomerular (e.g. glomerulonephritis)
  • Tubular (e.g. ATN)
  • Interstitial (e.g. AIN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What can cause direct tubular injury?

A
  • Ischaemia (MOST COMMON)
  • Endoengous toxins (e.g. myoglobin, immunoglobulin)
  • Exogenous toxins (e.g. aminoglycosides, amphotericin, aciclovir)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which diseases can cause AKI due to infiltration/abnormal protein deposition?

A
  • Amyloidosis (associated with nephrotic syndrome)
  • Lymphoma
  • Myeloma
17
Q

List the possible outcomes of AKI.

A
  • Partial recovery of renal function
  • Discharged with increased serum creatinine
  • Discharged requiring chronic dialysis
  • Death
18
Q

What are the biochemical definitions of AKI?

A
  • Increase in serum creatinine > 26.5µmol/L within 48 hours
  • Increase in serum creatinine > 1.5 times baseline within the previous 7 days
  • Urine volume < 0.5 ml/kg/hr for 6 hours
19
Q

What are the four processes of acute wound healing?

A
  • Haemostasis
  • Inflammation
  • Proliferation
  • Remodelling
20
Q

What are the stages of CKD?

A
  • Stage 1: >90
  • Stage 2: 60-89
  • Stage 3: 30-59
  • Stage 4: 15-29
  • Stage 5: <15
21
Q

List some causes of CKD.

A
  • Diabetes mellitus
  • Hypertension
  • Chronic glomerulnephritis
  • Atherosclerotic renal disease
  • Infective or obstructive uropathy
  • Polycystic kidney disease
22
Q

What are the normal roles of the kidney?

A
  • Excretion of water-soluble waste
  • Water balance
  • Electrolyte balance
  • Acid-base homeostasis
  • Endocrine (EPO, RAS, vitamin D)
23
Q

Outline the consequences of CKD.

A
  • Progressive failure of homeostatic function (acidosis, hyperkalaemia)
  • Progressive failure of hormonal function (anaemia, renal bone disease)
  • Cardiovascular disease (vascular calcifiction, uraemic cardiomyopathy)
  • Uraemia and death
24
Q

What are the consequences of renal acidosis?

A
  • Muscle and protein degradation
  • Osteopaenia due to mobilisation of bone calcium
  • Cardiac dysfunction
25
Q

How is renal acidosis treated?

A

Oral sodium bicarbonate

26
Q

What are the consequences of hyperkalaemia?

A
  • Cardiac dysfunction (arrhythmia)
  • Muscle dysfunction

NOTE: hyperkalaemia causes membrane depolarisation

27
Q

Which medications can cause hyperkalaemia?

A
  • ACE inhibitors
  • Spironolactone
  • Potassium-sparing diuretics
28
Q

What type of anaemia does chronic renal disease cause?

A

Normochromic, normocytic anaemia

29
Q

How is anaemia of chronic renal disease treated?

A
  • Erythropoietin alfa (Eprex)
  • Erythropoietin beta (NeoRecormon)
  • Darbopoietin (Aranesp)

NOTE: if CKD is not responding to erythropoiesis stimulating agents, consider iron deficiency, malignancy, B12 deficiency etc.

30
Q

List some types of renal bone disease.

A
  • Osteititis fibrosa cystica
  • Osteomalacia
  • Adynamic bone disease
  • Mixed osteodystrophy
31
Q

Outline the pathophysiology of renal bone disease.

A
  • Damaged kidneys are unable to excrete phosphate and activate vitamin D
  • Phosphate retention stimulates the production of FDF23 and Klotho
  • This lowers the levels of activated vitamin D
  • To try and get rid of the excess phosphate, the body will produce more PTH
  • Furthermore, to try and increase levels of vitamin D, the body will produce more PTH (i.e. there are two stimuli for PTH release)
  • High levels of PTH will result in the bone becoming resistant to PTH
32
Q

What is osteitis fibrosa cystica?

A

Caused by osteoclastic resoprtion of calcified bone and replacement by fibrous tissue (feature of hyperparathyroidism)

33
Q

What is adynamic bone disease?

A

Overtreatment leading to excessive suppression of PTH results in low bone turnover and reduced osteoid

34
Q

Outline the treatment of renal bone disease.

A
  • Phosphate control - dietary, phosphate binders
  • Vitamin D activators - 1-alpha calcidol, paricalcitol
  • Direct PTH suppression - cinacalcet (works by increasing the sensitivity of the calcium sensing receptor)
35
Q

What is the most important consequence of CKD?

A

Cardiovascular disease - this is most likely to kill them

36
Q

What are the three phases of uraemic cardiomyopathy?

A
  • LV hypertrophy
  • LV dilatation
  • LV dysfunction
37
Q

What are the treatment options for patients with CKD?

A
  • Transplantation
  • Haemodialysis
  • Peritoneal dialysis

YEAR 5 - CHEMPATH (26 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions